Clinical Trial Update: Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data

View source ↗

Summary

A clinical trial is exploring AI-based multimodal data to predict efficacy of targeted therapies in EGFR-mutant non-small cell lung cancer, with recruitment not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Non-small Cell Lung Cancer

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Lung Cancer (NSCLC), EGFR Activating Mutation | Status: NOT_YET_RECRUITING